Lumican expression, localization and antitumor activity in prostate cancer

Experimental Cell Research

Volumn 319, Issue 7, 2013, Pages 967-981

  Coulson Thomas, Vivien J ^a,b   Coulson Thomas, Yvette M ^a   Gesteira, Tarsis F ^a   Andrade de Paula, Claudia A ^a   Carneiro, Celia R W ^a   Ortiz, Valdemar ^a   Toma, Leny ^a   Kao, Winston W Y ^b   Nader, Helena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cell migration; Cytoskeleton; Desmoplasia; Lumican; Prostate cancer; Tumor markers

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; CORTACTIN; CYTOKERATIN 8; LUMICAN; MATRIX METALLOPROTEINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

MUS;

EID: 84874978949     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.023     Document Type: Article

References (65)

1. Proia D.A., Kuperwasser C. Stroma: tumor agonist or antagonist. Cell Cycle 2005, 4:1022-1025.
2. Coulson-Thomas V.J., Coulson-Thomas Y.M., Gesteira T.F., de Paula C.A., Mader A.M., Waisberg J., Pinhal M.A., Friedl A., Toma L., Nader H.B. Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res. 2011, 346:223-236.
3. Coulson-Thomas V.J., Gesteira T.F., Coulson-Thomas Y.M., Vicente C.M., Tersariol I.L., Nader H.B., Toma L. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-beta, and extracellular matrix down-regulation. Exp. Cell Res. 2010, 316:3207-3226.
4. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196:395-406.
5. Ruiter D., Bogenrieder T., Elder D., Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol. 2002, 3:35-43.
6. Wegrowski Y., Maquart F.X. Involvement of stromal proteoglycans in tumour progression. Crit. Rev. Oncol. Hematol. 2004, 49:259-268.
7. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 1998, 67:609-652.
8. Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., LaMantia C., Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell. Biol. 1998, 141:1277-1286.
9. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell. Biol. 1997, 136:729-743.
10. Kao W.W., Funderburgh J.L., Xia Y., Liu C.Y., Conrad G.W. Focus on molecules: lumican. Exp. Eye Res. 2006, 82:3-4.
11. Iozzo R.V. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 1997, 32:141-174.
12. Blochberger T.C., Cornuet P.K., Hassell J.R. Isolation and partial characterization of lumican and decorin from adult chicken corneas. A keratan sulfate-containing isoform of decorin is developmentally regulated. J. Biol. Chem. 1992, 267:20613-20619.
13. Funderburgh J.L., Funderburgh M.L., Brown S.J., Vergnes J.P., Hassell J.R., Mann M.M., Conrad G.W. Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique. J. Biol. Chem. 1993, 268:11874-11880.
14. Funderburgh J.L., Funderburgh M.L., Hevelone N.D., Stech M.E., Justice M.J., Liu C.Y., Kao W.W., Conrad G.W. Sequence, molecular properties, and chromosomal mapping of mouse lumican. Invest. Ophthalmol. Vis. Sci. 1995, 36:2296-2303.
15. Hayashida Y., Akama T.O., Beecher N., Lewis P., Young R.D., Meek K.M., Kerr B., Hughes C.E., Caterson B., Tanigami A., Nakayama J., Fukada M.N., Tano Y., Nishida K., Quantock A.J. Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:13333-13338.
16. Saika S., Miyamoto T., Tanaka S., Tanaka T., Ishida I., Ohnishi Y., Ooshima A., Ishiwata T., Asano G., Chikama T., Shiraishi A., Liu C.Y., Kao C.W., Kao W.W. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest. Ophthalmol. Vis. Sci. 2003, 44:2094-2102.
17. Yeh L.K., Chen W.L., Li W., Espana E.M., Ouyang J., Kawakita T., Kao W.W., Tseng S.C., Liu C.Y. Soluble lumican glycoprotein purified from human amniotic membrane promotes corneal epithelial wound healing. Invest. Ophthalmol. Vis. Sci. 2005, 46:479-486.
18. L. Liu, J. Wu, X. Zhou, Z. Chen, G. Zhou, The impact of visible light on the immature retina: a model of early light exposure in neonatal mice, Brain Res. Bull. 87 534-539.
19. Hassell J.R., Newsome D.A., Krachmer J.H., Rodrigues M.M. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc. Nat. Acad. Sci. U.S.A. 1980, 77:3705-3709.
20. Chakravarti S., Magnuson T. Localization of mouse lumican (keratan sulfate proteoglycan) to distal chromosome 10. Mamm. Genome 1995, 6:367-368.
21. Funderburgh J.L., Funderburgh M.L., Mann M.M., Conrad G.W. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J. Biol. Chem. 1991, 266:24773-24777.
22. Qin H., Ishiwata T., Asano G. Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cells in vitro. J. Pathol. 2001, 195:604-608.
23. Dolhnikoff M., Morin J., Roughley P.J., Ludwig M.S. Expression of lumican in human lungs. Am. J. Respir. Cell Mol. Biol. 1998, 19:582-587.
24. Schaefer L., Grone H.J., Raslik I., Robenek H., Ugorcakova J., Budny S., Schaefer R.M., Kresse H. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int. 2000, 58:1557-1568.
25. Sztrolovics R., Alini M., Mort J.S., Roughley P.J. Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine (Phila Pa 1976) 1999, 24:1765-1771.
26. Grover J., Chen X.N., Korenberg J.R., Roughley P.J. The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J. Biol. Chem. 1995, 270:21942-21949.
27. Ping Y., Ishiwata Lu, T., Asano G. Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J. Pathol. 2002, 196:324-330.
28. Funderburgh J.L., Mitschler R.R., Funderburgh M.L., Roth M.R., Chapes S.K., Conrad G.W. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest. Ophthalmol. Vis. Sci. 1997, 38:1159-1167.
29. Baba H., Ishiwata T., Takashi E., Xu G., Asano G. Expression and localization of lumican in the ischemic and reperfused rat heart. Jpn. Circ. J. 2001, 65:445-450.
30. Lu Y.P., Ishiwata T., Kawahara K., Watanabe M., Naito Z., Moriyama Y., Sugisaki Y., Asano G. Expression of lumican in human colorectal cancer cells. Pathol. Int. 2002, 52:519-526.
31. Saika S., Shiraishi A., Liu C.Y., Funderburgh J.L., Kao C.W., Converse R.L., Kao W.W. Role of lumican in the corneal epithelium during wound healing. J. Biol. Chem. 2000, 275:2607-2612.
32. Yeh J.T., Yeh L.K., Jung S.M., Chang T.J., Wu H.H., Shiu T.F., Liu C.Y., Kao W.W., Chu P.H. Impaired skin wound healing in lumican-null mice. Br. J. Dermatol. 2010, 163:1174-1180.
33. Rowley D.R. What might a stromal response mean to prostate cancer progression?. Cancer Metastasis. Rev. 1998, 17:411-419.
34. D'Onofrio M.F., Brezillon S., Baranek T., Perreau C., Roughley P.J., Maquart F.X., Wegrowski Y. Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican. Biochem. Biophys. Res. Commun. 2008, 365:266-272.
35. Seomun Y., Joo C.K. Lumican induces human corneal epithelial cell migration and integrin expression via ERK 1/2 signaling. Biochem. Biophys. Res. Commun. 2008, 372:221-225.
36. Koninger J., Giese T., di Mola F.F., Wente M.N., Esposito I., Bachem M.G., Giese N.A., Buchler M.W., Friess H. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem. Biophys. Res. Commun. 2004, 322:943-949.
37. Leygue E., Snell L., Dotzlaw H., Hole K., Hiller-Hitchcock T., Roughley P.J., Watson P.H., Murphy L.C. Expression of lumican in human breast carcinoma. Cancer Res. 1998, 58:1348-1352.
38. Naito Z., Ishiwata T., Kurban G., Teduka K., Kawamoto Y., Kawahara K., Sugisaki Y. Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int. J. Oncol. 2002, 20:943-948.
39. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 2003, 9:207-214.
40. Brezillon S., Venteo L., Ramont L., D'Onofrio M.F., Perreau C., Pluot M., Maquart F.X., Wegrowski Y. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin. Exp. Dermatol. 2007, 32:405-416.
41. Vuillermoz B., Khoruzhenko A., D'Onofrio M.F., Ramont L., Venteo L., Perreau C., Antonicelli F., Maquart F.X., Wegrowski Y. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 2004, 296:294-306.
42. Sifaki M., Assouti M., Nikitovic D., Krasagakis K., Karamanos N.K., Tzanakakis G.N. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 2006, 58:606-610.
43. Brezillon S., Radwanska A., Zeltz C., Malkowski A., Ploton D., Bobichon H., Perreau C., Malicka-Blaszkiewicz M., Maquart F.X., Wegrowski Y. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett. 2009, 283:92-100.
44. Zeltz C., Brezillon S., Kapyla J., Eble J.A., Bobichon H., Terryn C., Perreau C., Franz C.M., Heino J., Maquart F.X., Wegrowski Y. Lumican inhibits cell migration through alpha2beta1 integrin. Exp. Cell Res. 2010, 316:2922-2931.
45. Radwanska A., Litwin M., Nowak D., Baczynska D., Wegrowski Y., Maquart F.X., Malicka-Blaszkiewicz M. Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization. Exp. Cell Res. 2012, 318:2312-2323.
46. Nikitovic D., Chalkiadaki G., Berdiaki A., Aggelidakis J., Katonis P., Karamanos N.K., Tzanakakis G.N. Lumican regulates osteosarcoma cell adhesion by modulating TGFbeta2 activity. Int. J. Biochem. Cell Biol. 2011, 43:928-935.
47. Alves M.L., Straus A.H., Takahashi H.K., Michelacci Y.M. Production and characterization of monoclonal antibodies to shark cartilage proteoglycan. Braz. J. Med. Biol. Res. 1994, 27:2103-2108.
48. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
49. Holland J.W., Meehan K.L., Redmond S.L., Dawkins H.J. Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican. Prostate 2004, 59:252-259.
50. Fullwood N.J., Davies Y., Nieduszynski I.A., Marcyniuk B., Ridgway A.E., Quantock A.J. Cell surface-associated keratan sulfate on normal and migrating corneal endothelium. Invest. Ophthalmol. Vis. Sci. 1996, 37:1256-1270.
51. Kao W.W. Ocular surface tissue morphogenesis in normal and disease states revealed by genetically modified mice. Cornea 2006, 25:S7-S19.
52. Williams K.E., Fulford L.A., Albig A.R. Lumican reduces tumor growth via induction of fas-mediated endothelial cell apoptosis. Cancer Microenviron. 2011, 4:115-126.
53. Radwanska A., Baczynska D., Nowak D., Brezillon S., Popow A., Maquart F.X., Wegrowski Y., Malicka-Blaszkiewicz M. Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci. 2008, 83:651-660.
54. T. Busch, M. Armacki, T. Eiseler, G. Joodi, C. Temme, J. Jansen, G. von Wichert, M.B. Omary, J. Spatz, T. Seufferlein, Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells, J. Cell Sci. 125 2148-2159.
55. Fillies T., Werkmeister R., Packeisen J., Brandt B., Morin P., Weingart D., Joos U., Buerger H. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer 2006, 6:10.
56. Schaafsma H.E., Van Der Velden L.A., Manni J.J., Peters H., Link M., Rutter D.J., Ramaekers F.C. Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J. Pathol. 1993, 170:77-86.
57. H. Alam, S.T. Kundu, S.N. Dalal, M.M. Vaidya, Loss of keratins 8 and 18 leads to alterations in alpha6beta4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line, J. Cell Sci. 124 2096-2106.
58. Y. Yamashiro, K. Takei, M. Umikawa, T. Asato, M. Oshiro, Y. Uechi, T. Ishikawa, K. Taira, H. Uezato, K. Kariya, Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma, Biochem. Biophys. Res. Commun. 399 365-372.
59. Woll S., Windoffer R., Leube R.E. Dissection of keratin dynamics: different contributions of the actin and microtubule systems. Eur. J. Cell Biol. 2005, 84:311-328.
60. Jing J., Tarbutton E., Wilson G., Prekeris R. Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton. Eur. J. Cell Biol. 2009, 88:325-341.
61. Yamada H., Abe T., Li S.A., Masuoka Y., Isoda M., Watanabe M., Nasu Y., Kumon H., Asai A., Takei K. Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem. Biophys. Res. Commun. 2009, 390:1142-1148.
62. H. Jaafar, S.E. Sharif, M.D. Murtey, Distinctive features of advancing breast cancer cells and interactions with surrounding stroma observed under the scanning electron microscope, Asian Pac. J. Cancer Prev. 13 1305-1310.
63. Taliana L., Benezra M., Greenberg R.S., Masur S.K., Bernstein A.M. ZO-1: lamellipodial localization in a corneal fibroblast wound model. Invest. Ophthalmol. Vis. Sci. 2005, 46:96-103.
64. Tuomi S., Mai A., Nevo J., Laine J.O., Vilkki V., Ohman T.J., Gahmberg C.G., Parker P.J., Ivaska J. PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells. Sci. Signal 2009, 2. ra32.
65. Polette M., Mestdagt M., Bindels S., Nawrocki-Raby B., Hunziker W., Foidart J.M., Birembaut P., Gilles C. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007, 185:61-65.